Total Payments
$8,359
2024 Payments
$1,245
Companies
49
Transactions
750
Medicare Patients
2,429
Medicare Billing
$174,296
Payment Breakdown by Category
Food & Beverage$8,260 (98.8%)
Education$98.28 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,260 | 743 | 98.8% |
| Education | $98.28 | 7 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $870.96 | 145 | $0 (2024) |
| Novo Nordisk Inc | $860.85 | 102 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $853.30 | 46 | $0 (2024) |
| GlaxoSmithKline, LLC. | $721.84 | 70 | $0 (2024) |
| Lilly USA, LLC | $684.89 | 62 | $0 (2024) |
| ABBVIE INC. | $564.96 | 50 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $520.72 | 37 | $0 (2024) |
| Amgen Inc. | $431.23 | 29 | $0 (2024) |
| Merck Sharp & Dohme LLC | $389.94 | 45 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $255.33 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,245 | 76 | ABBVIE INC. ($231.88) |
| 2023 | $798.72 | 60 | AbbVie Inc. ($257.19) |
| 2022 | $457.34 | 26 | PFIZER INC. ($86.24) |
| 2021 | $413.63 | 28 | SANOFI-AVENTIS U.S. LLC ($47.05) |
| 2020 | $468.50 | 32 | GlaxoSmithKline, LLC. ($82.29) |
| 2019 | $1,629 | 169 | PFIZER INC. ($215.31) |
| 2018 | $1,717 | 173 | AstraZeneca Pharmaceuticals LP ($278.69) |
| 2017 | $1,630 | 186 | AstraZeneca Pharmaceuticals LP ($241.62) |
All Payment Transactions
750 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Obesity | ||||||
| 11/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $30.61 | General |
| Category: Insulin Pump | ||||||
| 10/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Gastroenterology | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Biological | ||||||
| 10/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Bone Health | ||||||
| 09/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.11 | General |
| Category: Cardiovascular | ||||||
| 08/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.05 | General |
| 08/15/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $30.32 | General |
| Category: Insulin Pump | ||||||
| 08/12/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: PAIN | ||||||
| 08/09/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 443 | 730 | $118,406 | $26,093 |
| 2022 | 10 | 514 | 813 | $125,919 | $27,222 |
| 2021 | 13 | 705 | 1,013 | $141,200 | $62,356 |
| 2020 | 20 | 767 | 1,273 | $132,097 | $58,625 |
Total Patients
2,429
Total Services
3,829
Medicare Billing
$174,296
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 318 | $72,350 | $14,016 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 146 | $23,386 | $5,302 | 22.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 78 | 78 | $17,944 | $3,783 | 21.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 16 | 32 | $1,292 | $1,115 | 86.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 55 | 106 | $1,802 | $1,009 | 56.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 50 | 50 | $1,632 | $867.50 | 53.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 174 | 363 | $82,035 | $16,131 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 105 | 130 | $20,716 | $4,849 | 23.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 72 | 72 | $16,575 | $3,200 | 19.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 53 | 101 | $1,717 | $962.28 | 56.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 46 | 46 | $1,472 | $802.59 | 54.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 15 | 16 | $1,472 | $610.27 | 41.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 12 | 13 | $1,274 | $385.74 | 30.3% |
| 85610 | Blood test, clotting time | Office | 2022 | 11 | 45 | $315.00 | $190.73 | 60.5% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2022 | 11 | 11 | $279.00 | $54.88 | 19.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 15 | 16 | $64.00 | $35.72 | 55.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 181 | 379 | $79,127 | $30,866 | 39.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 79 | 79 | $16,770 | $10,313 | 61.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 117 | 168 | $23,753 | $8,846 | 37.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 67 | 67 | $5,897 | $4,364 | 74.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 15 | 15 | $4,377 | $2,486 | 56.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 73 | 73 | $3,358 | $1,182 | 35.2% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 54 | 111 | $1,887 | $1,069 | 56.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 57 | 57 | $1,770 | $1,030 | 58.2% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 11 | 11 | $968.00 | $717.86 | 74.2% |
About Dr. Daniel Badenhop, M.D
Dr. Daniel Badenhop, M.D is a Family Medicine healthcare provider based in Marysville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376594168.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Badenhop, M.D has received a total of $8,359 in payments from pharmaceutical and medical device companies, with $1,245 received in 2024. These payments were reported across 750 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($8,260).
As a Medicare-enrolled provider, Badenhop has provided services to 2,429 Medicare beneficiaries, totaling 3,829 services with total Medicare billing of $174,296. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Marysville, OH
- Active Since 05/15/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1376594168
Products in Payments
- FARXIGA (Drug) $691.69
- TRELEGY ELLIPTA (Drug) $368.37
- JARDIANCE (Drug) $342.68
- CHANTIX (Drug) $310.16
- Ozempic (Drug) $251.80
- Victoza (Drug) $246.37
- XIFAXAN (Drug) $246.27
- TRADJENTA (Drug) $214.04
- QULIPTA (Drug) $195.70
- Omnipod (Device) $195.13
- EMGALITY (Drug) $185.88
- ELIQUIS (Drug) $176.52
- Trintellix (Drug) $176.09
- LYRICA (Drug) $172.62
- XARELTO (Drug) $167.96
- VRAYLAR (Drug) $163.67
- JANUVIA (Drug) $161.57
- Tresiba (Drug) $153.59
- UBRELVY (Drug) $146.34
- ANORO (Drug) $137.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Marysville
Dr. John Colombo, Md, MD
Family Medicine — Payments: $14,480
Family Medicine $14,480
Dr. Delia Herzog, M.d, M.D
Family Medicine — Payments: $8,380
Family Medicine $8,380
Dr. Jeffrey Moore, M.d, M.D
Family Medicine — Payments: $5,818
Family Medicine $5,818
Dr. Wendy Summerhill, M.d, M.D
Family Medicine — Payments: $4,265
Family Medicine $4,265
Igor Nedic, M.d, M.D
Family Medicine — Payments: $2,191
Family Medicine $2,191
Michael Shaffer, Md, MD
Family Medicine — Payments: $1,975
Family Medicine $1,975